N/A
N=200
Amyotrophic Lateral Sclerosis Registry Rhineland-Palatinate
Amyotrophic Lateral Sclerosis
Bottom Line
View on ClinicalTrials.gov: NCT01955369 ↗Enrolled (actual)
200
Serious AEs
0.0%
Results posted
Apr 2015
Primary outcome: Primary: Death — 134 participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Klinikum Ludwigshafen
- Primary completion
- Sep 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Death |
134 | — |
| SECONDARY Tracheostomy |
10 | — |
Summary
There is a lack of prospective and population-based epidemiological data on amyotrophic lateral sclerosis in Germany so far. The purpose of this registry is to investigate the incidence, course and phenotypic variety of ALS in Rhineland-Palatinate, a South-West German state of about 4 million inhabitants.
Eligibility Criteria
Inclusion Criteria
- diagnosis of amyotrophic lateral sclerosis according to revised El Escorial criteria
- minimum of 18 years
- minimum of 6 months of residency in Rhinelnad-Palatinate
Exclusion Criteria
- patients below 18 years
- ALS patients outside Rhineland-Palatinate
Data sourced from ClinicalTrials.gov (NCT01955369). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.